共 131 条
[1]
Banerjee S(2015)Multimorbidity—older adults need health care that can count past one Lancet 385 587-589
[2]
Salive ME(2013)Multimorbidity in older adults Epidemiol Rev 35 75-83
[3]
Mehta RS(2021)Emerging approaches to polypharmacy among older adults Nat Aging. 1 347-356
[4]
Kochar BD(2017)What is polypharmacy? A systematic review of definitions BMC Geriatr 17 230-704
[5]
Kennelty K(2012)Polypharmacy in nursing home in Europe: results from the SHELTER study J Gerontol A Biol Sci Med Sci 67 698-539
[6]
Masnoon N(2022)Drug-related problems and polypharmacy in nursing home residents: a cross-sectional study Int J Environ Res Public Health 19 4313-351
[7]
Shakib S(2023)Polypharmacy in nursing homes: options to improve drug therapy safety Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 66 530-1071
[8]
Kalisch-Ellett L(2020)Assessing nursing homes quality indicators’ between-provider variability and reliability: a cross-sectional study using ICCs and rankability Int J Environ Res Public Health 17 9249-221
[9]
Onder G(2020)An overview of prevalence, determinants and health outcomes of polypharmacy Ther Adv Drug Saf. 11 2042098620933741-352
[10]
Liperoti R(2007)Polypharmacy in elderly patients Am J Geriatr Pharmacother 5 345-94